The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Long-Term Treatment of Girls with Ornithine Transcarbamylase Deficiency
Open accessAbstract
BACKGROUND: Ornithine transcarbamylase is an X-linked mitochondrial enzyme that catalyzes the synthesis of citrulline from carbamoyl phosphate and ornithine. A deficiency of this enzyme leads to hyperammonemia and hyperglutaminemia. In boys the disease is often fatal when its onset occurs during the neonatal period, but it is milder when onset occurs later in childhood. Heterozygous girls may be normal or may have episodes of hyperammonemic encephalopathy and decline in cognitive function. We report here on the long-term outcome in girls with ornithine transcarbamylase deficiency enrolled in studies of treatments designed to activate new pathways of waste-nitrogen excretion. METHODS: We studied 32 girls (age, 1 to 17 years) with ornithine transcarbamylase deficiency who had had at least one episode of encephalopathy. The patients were assigned to treatment that consisted of sodium benzoate, alone or in combination with sodium phenylacetate or sodium phenylbutyrate, or sodium phenylbutyrate alone. Collaborating physicians provided clinical, metabolic, and developmental data at specified intervals. RESULTS: Patients treated according to these protocols had greater than 90 percent survival at five years and maintained appropriate weight for height. The frequency of hyperammonemic episodes decreased with increasing age and with sodium phenylacetate or sodium phenylbutyrate treatment. Although the mean IQ before treatment was in the low average range, 19 of the 23 girls in whom intelligence was tested longitudinally had stable test scores. CONCLUSIONS: Girls with symptomatic ornithine transcarbamylase deficiency who are treated with drugs that activate new pathways of waste-nitrogen excretion have fewer hyperammonemic episodes and a reduced risk of further cognitive decline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Manual for the Wechsler intelligence scale for children
Wechsler, D. (1974) · Psychological Corp. eBooks · Cited by 1,303
Dibley, M. J., Goldsby, J. B., Staehling, N. W., & Trowbridge, F. L. (1987) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/46.5.736 · Cited by 482
Msall, M., Batshaw, M. L., Suss, R., Brusilow, S. W., & Mellits, E. D. (1984) · New England Journal of Medicine · doi:10.1056/nejm198406073102304 · Cited by 411
Self-citationUrea Cycle Disorders: Diagnosis, Pathophysiology, and Therapy
Brusilow, S. W., & Maestri, N. E. (1996) · Advances in Pediatrics · doi:10.1016/s0065-3101(24)00072-0 · Cited by 353
Self-citationTreatment of Episodic Hyperammonemia in Children with Inborn Errors of Urea Synthesis
Brusilow, S. W., Danney, M., Waber, L. J., Batshaw, M., Burton, B., Levitsky, L., Roth, K., McKeethren, C., & Ward, J. (1984) · New England Journal of Medicine · doi:10.1056/nejm198406213102503 · Cited by 231
Self-citationNatural history of symptomatic partial ornithine transcarbamylase deficiency
Rowe, P. C., Newman, S. L., & Brusilow, S. W. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602273140903 · Cited by 135
Risk of serious illness in heterozygotes for ornithine transcarbamylase deficency
Batshaw, M. L., Msall, M. E., Beaudet, A. L., & Trojak, J. E. (1986) · The Journal of Pediatrics · doi:10.1016/s0022-3476(86)80989-1 · Cited by 132
Cerebral Dysfunction in Asymptomatic Carriers of Ornithine Transcarbamylase Deficiency
Batshaw, M. L., Roan, Y., Jung, A. L., Rosenberg, L. A., & Brusilow, S. W. (1980) · New England Journal of Medicine · doi:10.1056/nejm198002283020902 · Cited by 129
Self-citationLate-onset ornithine transcarbamylase deficiency in male patients
Finkelstein, J. E., Hauser, E. R., Leonard, C. O., & Brusilow, S. W. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80129-5 · Cited by 107
Self-citationRestoration of nitrogen homeostasis in a man with ornithine transcarbamylase deficiency
Brusilow, S. W., & Finkelstien, J. (1993) · Metabolism · doi:10.1016/0026-0495(93)90135-b · Cited by 32
Self-citation
Cited by
Özcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
Endoplasmic Reticulum Stress Plays a Central Role in Development of Leptin Resistance
Ozcan, L., Ergin, A. S., Lu, A., Chung, J., Sarkar, S., Nie, D., Myers, M. G., & Ozcan, U. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2008.12.004 · Cited by 875
Suggested guidelines for the diagnosis and management of urea cycle disorders
Häberle, J., Boddaert, N., Burlina, A., Chakrapani, A., Dixon, M., Huemer, M., Karall, D., Martinelli, D., Crespo, P., Santer, R., et al. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-32 · Cited by 628
Leptin, Obesity, and Leptin Resistance: Where Are We 25 Years Later
Izquierdo, A. G., Crujeiras, A. B., Casanueva, F. F., & Carreira, M. C. (2019) · Nutrients · doi:10.3390/nu11112704 · Cited by 525
Warrell, R. P., He, L.-Z., Richon, V., Calleja, E., & Pandolfi, P. P. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.21.1621 · Cited by 502
Metadata
- Authors
- Maestri, N. E., Brusilow, S. W., Clissold, D. B., & Bassett, S. S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1996-09-19
- Volume
- 335
- Issue
- 12
- Pages
- 855-860
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1972799369
- Cited by
- 258
- References
- 11
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-Term Treatment of Girls with Ornithine Transcarbamylase Deficiency. https://app.cochat.ai/papers/10.1056/nejm199609193351204
- The paper
- Maestri, N. E., Brusilow, S. W., Clissold, D. B., & Bassett, S. S. (1996). Long-Term Treatment of Girls with Ornithine Transcarbamylase Deficiency. New England Journal of Medicine. https://doi.org/10.1056/nejm199609193351204
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.